Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine.
The relationship of the timing of drug administration to anticonvulsant efficacy against amygdala kindled seizures was studied. During kindling development, rats received carbamazepine (CBZ, 15mg/kg) before (CBZ-before) or after each amygdala stimulation (CBZ-after). After kindling to full seizures, when all animals were given CBZ before the stimulation, only the CBZ-after group showed a good anticonvulsant response. The rats that had received CBZ before (during development of kindled seizures) remained unresponsive to CBZ treatment (contingent inefficacy). When drug-naive or CBZ-after animals repeatedly received CBZ before electrical stimulation, they developed tolerance to its anticonvulsant effects (contingent tolerance). The tolerance could be reversed by a period of treatment with CBZ-after or by kindling the animal drug-free, but not by CBZ administration alone or by time off from both drug and seizures. These findings suggest that inefficacy and tolerance to CBZ may be affected by the temporal contingencies of drug administration and that responsiveness can be reinstated by altering these contingencies.
Weiss
S R
SR
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
Post
R M
RM
D000679:Amygdala / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002220:Carbamazepine / Q000008:administration & dosage / Q000494:pharmacology*; D004361:Drug Tolerance; D004558:Electric Stimulation; D007274:Injections, Intraperitoneal; D007696:Kindling, Neurologic / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008959:Models, Neurological; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D002220:Carbamazepine